Clik here to view.
BeiGene to Demonstrate Strength of Hematology Portfolio and Pipeline at...
CAMBRIDGE, Mass., BEIJING & BASEL, Switzerland BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and affordable...
View ArticleClik here to view.
CANbridge to Present CAN106 Phase 1 Data at the European Hematology...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals, Inc. (HKEX:1228), a China-based global biopharmaceutical company committed to the research, development and commercialization of...
View ArticleClik here to view.
武田实现强劲的2021财年业绩；预计增长势头将在2022财年持续
日本大阪 (美国商业资讯)–武田(Takeda, TOKYO:4502/NYSE:TAK)今天公布了强劲的2021财年业绩（截至2022年3月21日的期间）。该业绩得益于公司增长型产品的表现、新产品的推出以及在其关键业务领域的实力。 武田总裁兼首席执行官Christophe...
View ArticleClik here to view.
PharmaEssentia Announces Appointment of Meredith Manning to President of the...
BURLINGTON, Mass. PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator leveraging deep expertise and proven scientific...
View ArticleClik here to view.
MSITEK Sponsors a Hospice IT and Digital Project in India as Part of CSR...
PRINCETON, N.J. & BANGALORE, India MSITEK, a global provider of SAP technology-enabled business solutions, recently collaborated with Ganga Prem Hospice, a Hospice care organization that...
View ArticleClik here to view.
City of Hope and Imugene Announce First Patient Dosed in Phase 1 Trial to...
SYDNEY & LOS ANGELES Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in the United States,...
View ArticleClik here to view.
Propanc Biopharma Undertaking PRP Manufacturing ＆ Development for Human Use
MELBOURNE, Australia Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
Clik here to view.
Clik here to view.
Clik here to view.
Sermo调查显示，今年ASCO的与会肿瘤学家对新的肺癌和乳腺癌研究最感兴趣
纽约 医生优先的在线社区、全球医疗保健提供者(HCP)洞察领导者Sermo的一项新调查发现，在美国临床肿瘤学会(ASCO)年会期间，近一半(47%)的与会肿瘤学家对肺癌的新数据最感兴趣。紧随其后的是乳腺癌相关新数据，高达44%的受访肿瘤学家表示对此最感兴趣，此外，54%的肿瘤学家/血液学家表示最有兴趣了解肿瘤靶向抗体疗法。...
View ArticleClik here to view.
B dot Medical: Successful Proof of Concept for Ultra-compact Proton Therapy...
TOKYO B dot Medical Inc. and Research Center for Nuclear Physics, Osaka University (RCNP) have conducted a Proof of Concept (POC) of the ultra-compact proton therapy system under development and...
View ArticleClik here to view.
Genexine Appoints Industry Veteran Neil Warma as Chief Executive Officer to...
SEOUL, South Korea Genexine (KOSDAQ: 095700) a publicly traded, clinical stage biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of unmet...
View ArticleClik here to view.
InnoCare Announces Approval to Conduct a Phase II Clinical Trial of...
BEIJING InnoCare Pharma (HKEX: 09969) announced today that it has received approval to conduct a single-arm, open-label, multicenter phase II clinical trial evaluating the safety and efficacy of...
View ArticleClik here to view.
BTIG to Host Inaugural China Biotech Day on Wednesday, June 1, 2022
NEW YORK BTIG announced today that it will hold an inaugural China Biotech Day, on Wednesday, June 1, 2022. This virtual event will include thematic panel discussions, fireside chats and one-on-one...
View ArticleClik here to view.
BeiGene Clinical Data Presentations at 2022 ASCO Annual Meeting Demonstrate...
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and...
View ArticleClik here to view.
MEI Pharma and Kyowa Kirin Announce Acceptance of Abstract for Presentation...
SAN DIEGO & TOKYO MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global...
View ArticleClik here to view.
Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing...
CAMBRIDGE, Mass. & OSAKA, Japan & BOTHELL, Wash. Takeda Pharmaceutical Company Limited (TSE:4502) and Seagen Inc., (NASDAQ:SGEN) today announced that overall survival (OS) data from the...
View ArticleClik here to view.
LintonPharm to Release Data on Catumaxomab for Advanced Gastric Cancer with...
GUANGZHOU, China LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging bispecific antibodies for cancer immunotherapy, announces that...
View ArticleClik here to view.
卡妥索单抗治疗晚期胃癌伴腹膜转移临床研究成果入选2022ASCO年会
中国广州 (美国商业资讯)–凌腾医药，一家专注于T细胞衔接抗体开发的临床阶段生物制药公司，今日宣布，美国临床肿瘤学会（American Society of Clinical Oncology, ASCO）已接收卡妥索单抗治疗晚期胃癌伴腹膜转移的Ⅲ期临床试验第一阶段研究成果作为摘要发布。 摘要编号：e16102 摘要标题：Global multi-center phase I trial of...
View Article